Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04978610 · ClinicalTrials.gov registry record · NA
Virtual ACT for Adolescent Stress
A NA study, sponsored by Children's Hospital Los Angeles.
- Terminated
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT04978610: Clinical Trial NA study, sponsored by Children's Hospital Los Angeles.
NCT04978610 is a NA study that was terminated before completion, run by Children's Hospital Los Angeles. The registered enrollment target is 14 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04978610, a NA study, was terminated before completion, sponsored by Children's Hospital Los Angeles.
- TERMINATED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
This study aims to test the effectiveness of a 6-week long virtual Acceptance Commitment group therapy as a non-pharmaceutical intervention to improving other functional outcomes for adolescents with a chronic medical condition in comparison to no treatment.
Primary Outcome
The Perceived Stress Scale (PSS) is the most widely used psychological instrument for measuring the perception of stress. Items were designed to tap how unpredictable, uncontrollable, and overloaded respondents find their lives. The scale also includes a number of direct queries about current levels of experienced stress. SS scores are obtained by reversing responses (e.g., 0 = 4, 1 = 3, 2 = 2, 3 = 1 \& 4 = 0) to the four positively stated items and then summing across all scale items with highe
Interventions
- BEHAVIORAL Virtual Acceptance Commitment Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2021-03-03 |
| Est. Completion | 2026-03-04 |
| Phase | NA |
Why NCT04978610 stopped before completion
NCT04978610 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Virtual Acceptance Commitment Therapy is the first listed.
NCT04978610 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04978610 about?
NCT04978610 is a clinical study titled "Virtual ACT for Adolescent Stress". This study aims to test the effectiveness of a 6-week long virtual Acceptance Commitment group therapy as a non-pharmaceutical intervention to improving other functional outcomes for adolescents with a chronic medical condition in comparison to no treatment.
What is the current status of trial NCT04978610?
This trial is currently terminated. It is a NA study. The enrollment target is 14 participants. The study started on 2021-03-03. Estimated completion is 2026-03-04.
What interventions are being tested in trial NCT04978610?
The interventions under investigation include: Virtual Acceptance Commitment Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT04978610?
This trial is sponsored by Children's Hospital Los Angeles, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04978610's enrollment target sits among peer trials
14 1909th of 2000 higher than 90 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy